KIT and acute myeloid leukemia: Gain-of-function mutations in c-KIT gene altered the hyperactivation of RTK and are associated with several human malignancies, such as gastrointestinal stromal tumors (GISTs), acute myeloid leukemia (AML), mast cell leukemia (MCL) and melanoma.